OR WAIT null SECS
September 30, 2022
PerkinElmer has unveiled a cell analysis solution to streamline cell and gene therapy research and manufacturing.
September 28, 2022
Actylis combines Aceto and its 10 acquired specialists into a singular global brand.
The collaboration will use Octagon’s functional target discovery approach and novel chemistry strategy in disease areas in which Novo Nordisk has specific expertise.
September 27, 2022
Roquette’s acquisition of Crest Cellulose is designed to reinforce its presence in India and other countries in Asia.
September 21, 2022
Lonza has expanded its HPAPI multipurpose suite for payload-linker manufacturing.
September 19, 2022
Civica is expanding in the greater Richmond-Petersburg region and investing $27.8 million in a new testing facility.
September 09, 2022
Charles River Laboratories and Cure AP-4 will collaborate on gene therapy manufacturing for AP-4 hereditary spastic paraplegia.
Avance Clinical’s acquisition of C3 Research Associates expands its CRO services to North America.
September 07, 2022
SIRIO is enhancing its strategy for small and medium nutrition brands as Lonza’s Sara Lesina joins as GM in Europe.
September 06, 2022
Hovione has expanded its drug product offering with a new manufacturing line dedicated to continuous tableting.